Biosimilars ‒ Policy failings that deny savings to countries that need it most

Market review Biosimilar medicines policy 2023 - Policy… 27 September 2023 The Biosimilar Market Access Committee (Biosimilar medicines Group, a Medicines…
Health Policy Watch: Forum Discusses High Drug Prices in… 12 February 2024 Adrian van den Hoven, chair of the International Generic and…
"Central Role For Industry Beckons As Europe Rebuilds After… 25 October 2021 Generics And Biosimilars Must Become A Central Policy Pillar, Says…
Biosimilars Market Review 2023 18 September 2023 The purpose of this Market Review is to provide a…